NanoTemper Technologies is proud to share that Dr. Philipp Baaske, co-founder and Executive Chairman of NanoTemper, has been appointed Economic Senator honoris causa (h. c.) by the Federal Economic Senate of the BVMW.
The honor was awarded on May 9, 2026, at the Hamburg Port Anniversary and recognizes individuals who have made outstanding contributions through economic or cultural engagement. For NanoTemper, the appointment reflects the entrepreneurial spirit and scientific ambition that have shaped the company since its founding.
From its beginnings in a university laboratory, NanoTemper has grown into an internationally active biotech company supporting scientists with biophysical precision instruments for drug discovery, biotechnology research, and biomanufacturing. This recognition reflects the importance of turning scientific excellence into practical impact – a principle that continues to guide NanoTemper as we create biophysical tools that help accelerate breakthroughs in human health.
